Neuroscience

Articles and news from the latest research reports.

260 notes

Major step toward an Alzheimer’s vaccine
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain’s natural defense mechanisms in people with Alzheimer’s disease. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer’s disease and a vaccine to prevent the illness.
One of the main characteristics of Alzheimer’s disease is the production in the brain of a toxic molecule known as amyloid beta. Microglial cells, the nervous system’s defenders, are unable to eliminate this substance, which forms deposits called senile plaques.
The team led by Dr. Serge Rivest, professor at Université Laval’s Faculty of Medicine and researcher at the CHU de Québec research center, identified a molecule that stimulates the activity of the brain’s immune cells. The molecule, known as MPL (monophosphoryl lipid A), has been used extensively as a vaccine adjuvant by GSK for many years, and its safety is well established.
In mice with Alzheimer’s symptoms, weekly injections of MPL over a twelve-week period eliminated up to 80% of senile plaques. In addition, tests measuring the mice’s ability to learn new tasks showed significant improvement in cognitive function over the same period.
The researchers see two potential uses for MPL. It could be administered by intramuscular injection to people with Alzheimer’s disease to slow the progression of the illness. It could also be incorporated into a vaccine designed to stimulate the production of antibodies against amyloid beta. “The vaccine could be given to people who already have the disease to stimulate their natural immunity,” said Serge Rivest. “It could also be administered as a preventive measure to people with risk factors for Alzheimer’s disease.”
"When our team started working on Alzheimer’s disease a decade ago, our goal was to develop better treatment for Alzheimer’s patients," explained Professor Rivest. "With the discovery announced today, I think we’re close to our objective."
(Photo: ALAMY)

Major step toward an Alzheimer’s vaccine

A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain’s natural defense mechanisms in people with Alzheimer’s disease. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer’s disease and a vaccine to prevent the illness.

One of the main characteristics of Alzheimer’s disease is the production in the brain of a toxic molecule known as amyloid beta. Microglial cells, the nervous system’s defenders, are unable to eliminate this substance, which forms deposits called senile plaques.

The team led by Dr. Serge Rivest, professor at Université Laval’s Faculty of Medicine and researcher at the CHU de Québec research center, identified a molecule that stimulates the activity of the brain’s immune cells. The molecule, known as MPL (monophosphoryl lipid A), has been used extensively as a vaccine adjuvant by GSK for many years, and its safety is well established.

In mice with Alzheimer’s symptoms, weekly injections of MPL over a twelve-week period eliminated up to 80% of senile plaques. In addition, tests measuring the mice’s ability to learn new tasks showed significant improvement in cognitive function over the same period.

The researchers see two potential uses for MPL. It could be administered by intramuscular injection to people with Alzheimer’s disease to slow the progression of the illness. It could also be incorporated into a vaccine designed to stimulate the production of antibodies against amyloid beta. “The vaccine could be given to people who already have the disease to stimulate their natural immunity,” said Serge Rivest. “It could also be administered as a preventive measure to people with risk factors for Alzheimer’s disease.”

"When our team started working on Alzheimer’s disease a decade ago, our goal was to develop better treatment for Alzheimer’s patients," explained Professor Rivest. "With the discovery announced today, I think we’re close to our objective."

(Photo: ALAMY)

Filed under alzheimer's disease vaccine amyloid beta senile plaques science

  1. liberalwithguts reblogged this from everyonelikedbubbahotep
  2. everyonelikedbubbahotep reblogged this from donna-old-blog
  3. wandless-magic reblogged this from neurosciencestuff
  4. donna-old-blog reblogged this from exclusively-positive-press
  5. superbuthuman reblogged this from thepursuitofselfactualization
  6. scottystylin reblogged this from newsandtrade
  7. newsandtrade reblogged this from truth-has-a-liberal-bias
  8. arcadiahomecare reblogged this from neurosciencestuff and added:
    This is a topic we’ve gone over before, now neurosciencestuff explores a new potential Alzheimer’s
  9. thepursuitofselfactualization reblogged this from neurosciencestuff
  10. cookiesnom reblogged this from comradechrisman
  11. benedictedatrocities reblogged this from thescienceblog
  12. worldconflictquarterly reblogged this from truth-has-a-liberal-bias
  13. ghostnineone reblogged this from thescienceblog
  14. thescienceblog reblogged this from neurosciencestuff
  15. matthewbartholomewesquire reblogged this from dragamyr
  16. dragamyr reblogged this from truth-has-a-liberal-bias
  17. ireallydontquiteknow reblogged this from truth-has-a-liberal-bias
  18. perfectmistakess reblogged this from oceann-ave
  19. blackjackchazzy reblogged this from theprofessorstrikesagain
  20. fullhousewithouttheolsentwins reblogged this from truth-has-a-liberal-bias
  21. the-depresso-gatsby reblogged this from truth-has-a-liberal-bias
  22. powpowhammer reblogged this from truth-has-a-liberal-bias
  23. just-thinkfuck-it reblogged this from neurosciencestuff
  24. scarybalkanlady reblogged this from truth-has-a-liberal-bias
  25. fueledbyboba reblogged this from truth-has-a-liberal-bias and added:
    this is amazing and all but I can’t help but be mad about this not happening sooner :/
  26. somanybears reblogged this from truth-has-a-liberal-bias
  27. lacedwithblasphemy reblogged this from truth-has-a-liberal-bias
  28. thewonderofliving reblogged this from truth-has-a-liberal-bias
  29. umph reblogged this from randomactsofchaos
free counters